KOTRA | KOTRA INDUSTRIES BHD
4.74 (0.64%)
T-O (am): 0.000 (08:59:00)
Last updated: 09:03
iSaham Fundamental Trend
FCON: | Sharpe Ratio: | LTS:
Quarter Reports
Select columns required and click "Update" to save your preferences
| Ann. Date | Qtr. Date | Q | FYE | Revenue [M] | PBT [M] | NP [M] | NPM | DPS | EPS | R. QoQ | R. YoY | E. QoQ | E. YoY | TTM EPS |
Adj. [M] |
NP [M] (adj) |
NPM (adj) |
EPS (adj) |
E. QoQ (adj) |
E. YoY (adj) |
TTM EPS (adj) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 21 Feb 24 | Q2 Dec 23 | 2 | 30 Jun 24 | 57.55 | 11.88 | 11.62 | 20.2% | 12.50 | 7.83 | 8.0% | 7.6% | 15.0% | 29.2% | ||||||||
| 28 Nov 23 | Q1 Sep 23 | 1 | 30 Jun 24 | 53.31 | 13.90 | 13.66 | 25.6% | 0.00 | 9.21 | 4.5% | 17.7% | 4.4% | 25.1% | ||||||||
| 23 Aug 23 | Q4 Jun 23 | 4 | 30 Jun 23 | 55.80 | 13.49 | 13.09 | 23.5% | 15.50 | 8.84 | 6.0% | 14.4% | 25.2% | 19.4% | ||||||||
| 26 May 23 | Q3 Mar 23 | 3 | 30 Jun 23 | 59.40 | 17.68 | 17.50 | 29.4% | 0.00 | 11.82 | 4.6% | 7.5% | 6.6% | 2.7% | ||||||||
| 24 Feb 23 | Q2 Dec 22 | 2 | 30 Jun 23 | 62.25 | 16.55 | 16.41 | 26.4% | 10.00 | 11.09 | 3.9% | 17.9% | 10.0% | 18.0% | ||||||||
| 29 Nov 22 | Q1 Sep 22 | 1 | 30 Jun 23 | 64.75 | 18.35 | 18.24 | 28.2% | 0.00 | 12.33 | 32.8% | 26.7% | 12.3% | 22.3% | ||||||||
| 29 Aug 22 | Q4 Jun 22 | 4 | 30 Jun 22 | 48.77 | 12.35 | 16.24 | 33.3% | 0.00 | 10.97 | 11.7% | 12.2% | 4.7% | 30.5% | ||||||||
| 30 May 22 | Q3 Mar 22 | 3 | 30 Jun 22 | 55.24 | 17.09 | 17.04 | 30.8% | 0.00 | 11.51 | 4.6% | 27.5% | 22.5% | 172.8% | ||||||||
| 24 Feb 22 | Q2 Dec 21 | 2 | 30 Jun 22 | 52.82 | 13.91 | 13.90 | 26.3% | 9.50 | 9.40 | 3.4% | 38.3% | 6.8% | 331.0% | ||||||||
| 26 Nov 21 | Q1 Sep 21 | 1 | 30 Jun 22 | 51.09 | 14.92 | 14.92 | 29.2% | 0.00 | 10.08 | 17.5% | 47.5% | 19.9% | 501.8% | ||||||||
| 02 Sep 21 | Q4 Jun 21 | 4 | 30 Jun 21 | 43.48 | 14.30 | 12.44 | 28.6% | 0.00 | 8.43 | 0.3% | 18.3% | 99.2% | 57.4% | ||||||||
| 28 May 21 | Q3 Mar 21 | 3 | 30 Jun 21 | 43.34 | 6.24 | 6.25 | 14.4% | 0.00 | 4.23 | 13.5% | 6.8% | 93.6% | 18.0% | ||||||||
| 19 Feb 21 | Q2 Dec 20 | 2 | 30 Jun 21 | 38.18 | 3.23 | 3.23 | 8.4% | 0.02 | 2.19 | 10.3% | 21.9% | 30.1% | 63.8% | ||||||||
| 20 Nov 20 | Q1 Sep 20 | 1 | 30 Jun 21 | 34.63 | 2.49 | 2.48 | 7.2% | 0.00 | 1.68 | 5.8% | 12.5% | 68.6% | 51.7% | ||||||||
| 14 Aug 20 | Q4 Jun 20 | 4 | 30 Jun 20 | 36.76 | 4.17 | 7.91 | 21.5% | 0.00 | 5.46 | 20.9% | 7.6% | 3.8% | 21.1% | ||||||||
| 22 May 20 | Q3 Mar 20 | 3 | 30 Jun 20 | 46.51 | 7.63 | 7.62 | 16.4% | 0.00 | 5.26 | 4.9% | 14.2% | 14.4% | 47.4% | ||||||||
| 05 Feb 20 | Q2 Dec 19 | 2 | 30 Jun 20 | 48.89 | 8.94 | 8.90 | 18.2% | 0.04 | 6.36 | 23.6% | 8.6% | 73.3% | 84.2% | ||||||||
| 28 Nov 19 | Q1 Sep 19 | 1 | 30 Jun 20 | 39.57 | 5.18 | 5.14 | 13.0% | 0.00 | 3.68 | 0.6% | 15.8% | 21.3% | 9.5% | ||||||||
| 22 Aug 19 | Q4 Jun 19 | 4 | 30 Jun 19 | 39.80 | 5.58 | 6.53 | 16.4% | 0.00 | 4.68 | 2.3% | 10.2% | 26.3% | 17.1% | ||||||||
| 17 May 19 | Q3 Mar 19 | 3 | 30 Jun 19 | 40.73 | 5.21 | 5.17 | 12.7% | 0.00 | 3.71 | 9.5% | 8.6% | 7.0% | 40.9% | ||||||||
| 19 Feb 19 | Q2 Dec 18 | 2 | 30 Jun 19 | 45.01 | 4.88 | 4.83 | 10.7% | 0.03 | 3.47 | 4.3% | 3.1% | 14.9% | 14.8% | ||||||||
| 22 Nov 18 | Q1 Sep 18 | 1 | 30 Jun 19 | 47.01 | 5.70 | 5.67 | 12.1% | 0.00 | 4.25 | 6.1% | 8.9% | 1.8% | 146.5% | ||||||||
| 21 Aug 18 | Q4 Jun 18 | 4 | 30 Jun 18 | 44.30 | 5.65 | 5.57 | 12.6% | 0.00 | 4.19 | 0.6% | 5.0% | 52.0% | 188.7% | ||||||||
| 14 May 18 | Q3 Mar 18 | 3 | 30 Jun 18 | 44.56 | 3.70 | 3.67 | 8.2% | 0.00 | 2.76 | 4.0% | 1.5% | 12.9% | 20.0% | ||||||||
| 13 Feb 18 | Q2 Dec 17 | 2 | 30 Jun 18 | 46.44 | 4.25 | 4.21 | 9.1% | 0.02 | 3.17 | 7.6% | 3.0% | 82.9% | 26.8% | ||||||||
| 23 Nov 17 | Q1 Sep 17 | 1 | 30 Jun 18 | 43.18 | 2.30 | 2.30 | 5.3% | 0.00 | 1.73 | 2.4% | 27.4% | 19.2% | 1670.0% | ||||||||
| 23 Aug 17 | Q4 Jun 17 | 4 | 30 Jun 17 | 42.18 | 2.06 | 1.93 | 4.6% | 0.00 | 1.46 | 6.7% | 3.2% | 57.9% | 32.5% | ||||||||
| 19 May 17 | Q3 Mar 17 | 3 | 30 Jun 17 | 45.22 | 4.58 | 4.58 | 10.1% | 0.00 | 3.46 | 0.3% | 7.0% | 20.3% | 578.1% | ||||||||
| 08 Feb 17 | Q2 Dec 16 | 2 | 30 Jun 17 | 45.07 | 5.75 | 5.75 | 12.8% | 0.02 | 4.34 | 33.0% | 14.6% | 4324.6% | 873.3% | ||||||||
| 23 Nov 16 | Q1 Sep 16 | 1 | 30 Jun 17 | 33.89 | 0.13 | 0.13 | 0.4% | 0.00 | 0.10 | 17.0% | 10.3% | 95.5% | 96.4% | ||||||||
| 29 Aug 16 | Q4 Jun 16 | 4 | 30 Jun 16 | 40.85 | 2.97 | 2.86 | 7.0% | 0.00 | 2.17 | 3.3% | 6.9% | 323.4% | 268.8% | ||||||||
| 25 May 16 | Q3 Mar 16 | 3 | 30 Jun 16 | 42.26 | 0.68 | 0.68 | 1.6% | 0.00 | 0.51 | 7.4% | 19.4% | 14.4% | 8.7% | ||||||||
| 25 Feb 16 | Q2 Dec 15 | 2 | 30 Jun 16 | 39.34 | 0.59 | 0.59 | 1.5% | 0.00 | 0.45 | 4.1% | 0.1% | 83.7% | 74.4% | ||||||||
| 26 Nov 15 | Q1 Sep 15 | 1 | 30 Jun 16 | 37.78 | 3.63 | 3.63 | 9.6% | 0.00 | 2.74 | 1.1% | 17.4% | 368.0% | 231.6% | ||||||||
| 27 Aug 15 | Q4 Jun 15 | 4 | 30 Jun 15 | 38.22 | 0.89 | 0.78 | 2.0% | 0.00 | 0.59 | 8.0% | 10.7% | 4.9% | 78.2% | ||||||||
| 27 May 15 | Q3 Mar 15 | 3 | 30 Jun 15 | 35.40 | 0.74 | 0.74 | 2.1% | 0.00 | 0.56 | 10.1% | 18.1% | 67.9% | 86.5% | ||||||||
| 16 Feb 15 | 31/12/14 | 2 | 30/06/15 | 39.39 | 2.31 | 2.31 | 5.8% | 0.00 | 1.74 | 22.4% | 11.0% | 183.5% | 13458.8% |
Historical Dividends
Financial Ratios
| EPS | 37.66 sen |
| Trailing PE (Sector Median: 16.5) | 12.6 |
| PEG | 12.6 |
| Altman Z | 2.5 |
| Beaver | 0.722 |
| Current Ratio | 3.46 |
| Debt-Equity (DE) Ratio | 0.19 |
| FCF Yield | 3.27 % |
| Revenue QoQ | 7.95 % |
| Revenue YoY | -7.56% |
| Profit QoQ | -14.96 % |
| Profit YoY | -29.22 % |
| Profit Margin (Sector Median: 7.9) | 24.71 % |
| ROE (ROIC: 20.34) | 20.34 % |
| Dividend Per Share (DPS) | 28.0 sen |
| Dividend Yield (DY) | 5.91 % |
Adjusted Financial Ratios
Ratios below have been recalculated after adjusting for One Off Gain/Loss detected from Quarterly reports
| EPS | |
| Trailing PE (Sector Median: 16.5) | |
| Profit QoQ | |
| Profit YoY | |
| Profit Margin (Sector Median: 7.9) | |
| ROE (ROIC: 19.37) | |
| Altman Z |
Fair Value
Weighted Average Fair Value:
| Discounted Cash Flow (DCF) 5% Growth | |
| Discounted Cash Flow (DCF) 10% Growth | |
| Relative Valuation | |
| Average Analysts FV based on 3 rating(s) |
| Graham Formula | |
| Graham Number | |
| Net Tangible Asset (NTA) | 1.85 | Consistent QR FV |
Advanced Calculators
Calculate the fair value of the stock based on expected growth / risk, contract / award value, forecasted profit or forecasted revenue.
| Forward PE FV Calculator | |
| Latest Profit (adjusted) [M] | 11.62 |
| Expected Profit (Next QR) [M] | |
| Expected Profit (After QR above) [M] | |
| Expected Profit (After QR above) [M] | |
| Estimated Fair Value |
| Growth/Risk Fair Value Calculator | |
| Expected growth (%) | |
| Estimated downside / risk (%) | |
| Estimated New DCF Fair Value |
| Contract/Award Contribution Calculator | |
| Contract/Award Value (in Million) | |
| Estimated Contribution to Stock Price | |
| Estimated New DCF Fair Value |
| Profit-Based Calculator | |
| Expected Profit (M) | |
| for Year | |
| Estimated New DCF Fair Value |
| Revenue-Based Calculator | |
| Expected Revenue (M) | |
| for Year | |
| Estimated New DCF Fair Value |
| Market Pricing | |
| Expected Profit (M) | 56.97 |
| Expected Revenue (M) | 438.53 |
| Expected Growth (%) | 20.0 |
Directors Share Purchases (Beta)
No transaction in the last 2 months.
Summary
Market Cap: 703 M.
Number of Shares: 148 M.
Adjusted Float: 56.4%.
Stock highly correlated with
KSSC (87%)
MHB (86%)
EIB (85%)
MUDAJYA (84%)
Kotra Industries Berhad, an investment holding company is engaged in developing, manufacturing and trading pharmaceutical and healthcare products in Malaysia and other countries in the Asia Pacific. Kotra Industries Berhad is a subsidiary of Piong Nam Kim Holdings Sdn. Bhd. It offers pharmaceutical products in various dosage forms, which include tablets, capsules, cream/ointment/gel, liquid, dry powder preparations and injectables. The company manufactures over-the-counter (OTC) products that include dietary supplements for infants and teenagers, multivitamin tablets and syrups for kids, vitamin and mineral supplements for pregnant and lactating women, antioxidant vitamins for adults, products for weight gain-related conditions, and wellness products for seniors. It also offers over-the-counter and prescription products, such as peripheral vasolidators, antacid and gastric ulcer remedies, antifungals, dermatologicals, anthelmentics, cough preparations, analgesics and antipyretics, mouth and throat preparations, and antirheumatics. The company's prescription products also include antihistamines/antiemetics, cold preparations, anti-asthmatics, anti-diarrhoeals, antibiotics, antivirals, corticosteroids, anaesthetics, vitamins and minerals, anti-inflammatory products, antispasmodics, antimalarials, anticoagulants and hormones and gynaecological products including Predicates ovulation test kits and Thames sperm enhancer kits. It offers OTC health supplements under Appeton brand, nutriceutical beverages under the Booster brand, anti-fungal Creobic Cream and a range of prescriptive products under Axcel and Vaxcel brand names. The company was incorporated in 1985 and is based in Melaka, Malaysia.
Sectors: Consumer Products, Healthcare, Pharmaceuticals
Code: 0002
Website: http://www.kotrapharma.com
Related Links: Bursa | Annual Report | Announcement
Warrant Info:
No warrants listed
Top Shareholdings
Updated on 29-Sep-2023
| Shareholder | % | Value (M) |
|---|---|---|
| Piong Nam Kim Holdings Sdn Bhd | 43.57% | 306.3 |
| Piong Teck Onn | 12.34% | 86.75 |
| Piong Teck Yen | 3.92% | 27.56 |
| Piong Teck Min | 3.38% | 23.76 |
| Piong Chee Wei | 2.55% | 17.93 |
| Platinum Essence Sdn. Bhd. | 1.89% | 13.29 |
| Kok Hon Seng | 1.69% | 11.88 |
| Cheah Chang Han | 1.65% | 11.6 |
| Chin Swee Chang | 1.56% | 10.97 |
| Ji Yeh Ming | 1.35% | 9.49 |
| Seah Tin Kim | 1.24% | 8.72 |
| Medisch Specialist Centre Sdn Bhd | 1.12% | 7.87 |
| Lim Kian Tiak | 1.01% | 7.1 |
| Ho Jonathan Lep Kee | 0.82% | 5.76 |
| Fong Siling | 0.81% | 5.69 |
| Cheah Ming Loong | 0.78% | 5.48 |
| Ooi Lee Peng | 0.61% | 4.29 |
| Piong Tech Fong | 0.53% | 3.73 |
| Triple Boutique Sdn Bhd | 0.52% | 3.66 |
| Piong Teck Wah | 0.52% | 3.66 |
| Sin Boon Fei | 0.42% | 2.95 |